Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kazuhide Nakatomi | President, CEO & Director | -- | -- | 1972 |
| Mr. Naruhito Higo | Executive VP, Head of Global Technology & Head of Quality Assurance Division | -- | -- | -- |
| Mr. Nobuo Tsutsumi | Exe Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director | -- | -- | 1964 |
| Mr. Kosuke Sugiyama | Executive MD of Human Resources, Research & Development, Corporate Planning and Director | -- | -- | 1952 |
| Tetsuo Akiyama | Senior Managing Executive Officer, Head of Business Operations & Head of BU | -- | -- | -- |
| Mr. Kyu Saito | MD, Executive Officer, GM of Global Business & Director | -- | -- | 1963 |
| Mr. Shinichi Murayama | Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | -- | -- | 1967 |
| Mitsutoshi Tsuruta | Senior Executive Officer & GM of Pharmaceutical Business Division | -- | -- | -- |
| Masaya Okuno | Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division | -- | -- | -- |
| Mr. Koji Takiyama | Executive Officer, GM of President's Office & Director | -- | -- | 1971 |
Hisamitsu Pharmaceutical Co., Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 2,759
Description
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Corporate Governance
Upcoming Events
February 27, 2025 at 12:00 AM UTC
Ex-Dividend Date
April 9, 2025 at 6:00 AM UTC - April 14, 2025 at 6:00 AM UTC
Hisamitsu Pharmaceutical Co., Inc. Earnings Date
Recent Events
Recent Events Information Not Available